조류인플루엔자 바이러스의 양-반응 모형 = Dose-Response Relationship of Avian Influenza Virus Based on Feeding Trials in Humans and Chickens

다국어 초록 (Multilingual Abstract)

This study aimed to determine dose-response (DR) curve of avian influenza (AI) virus to predict the probability of illness or adverse health effects that may result from exposure to a pathogenic microorganism in a quantitative microbial risk assessment. To determine the parametric DR relationship of several strains of AI virus, 7 feeding trial data sets challenging humans (5 sets) and chickens (2 sets) for strains of H3N2 (4 sets), H5N1 (2 sets) and H1N1(1 set) from the published literatures. Except for one data set (study with intra-tracheal inoculation for data set no.
6), all were obtained from the studies with intranasal inoculation. The data were analyzed using three types of DR model as the basis of heterogeneity in infectivity of AI strains in humans and chickens: exponential, beta-binomial and beta-Poisson. We fitted to the data using maximum likelihood estimation to get the parameter estimates of each model. The alpha and beta values of the beta-Poisson DR model ranged 0.06-0.19 and 1.7-48.8, respectively for H3N2strain. Corresponding values for H5N1 ranged 0.464-0.563 and 97.3-99.4, respectively. For H1N1 the parameter values were 0.103 and 12.7, respectively. Using the exponential model, r (infectivity parameter) ranged from 1.6 × 10-8 to 1.2 × 10-5 for H3N2 and from 7.5 × 10-3 to 4.0 × 10-2 for H5N1, while the value was 1.6 × 10-8 for H1N1. The beta-Poisson DR model provided the best fit to five of 7 data sets tested, and the estimated parameter values in betabinomial model were very close to those of beta-Poisson. Our study indicated that beta-binomial or beta-Poisson model could be the choice for DR modeling of AI, even though DR relationship varied depending on the virus strains studied,as indicated in prior studies. Further DR modeling should be conducted to quantify the differences among AI virus strains.

참고문헌 (Reference)

• 1 Zmirou-Navier D, "Waterborne microbial risk assessment: a population-based dose-response function for Giardia spp. (E.MI.R.A study)" 6 : 122-, 2006
• 2 Soller JA, "Use of microbial risk assessment to inform the national estimate of acute gastrointestinal illness attributable to microbes in drinking water" 4 : 165-186, 2006
• 3 Spekreijse D, "The effect of inoculation dose of a highly pathogenic avian influenza virus strain H5N1 on the infectiousness of chickens" 147 : 59-66, 2011
• 4 Teunis P, "The beta poisson dose-response models is not a single hit model" 20 : 513-520, 2000
• 5 Brown JD, "Susceptibility of wood ducks to H5N1 highly pathogenic avian influenza virus" 43 : 660-667, 2007
• 6 Hinshaw VS, "Replication of avian influenza A viruses in mammals" 34 : 354-361, 1981
• 7 Schijven JF, "Quantitative risk analysis of avian influenza virus infection in water" RIVM 2005
• 8 Haas CN, "Quantitative microbial risk assessment" Wiley 260-319, 1999
• 9 Swayne DE, "Occupational and consumer risks from avian influenza viruses" 124 : 85-90, 2006
• 10 Ito T, "Molecular basis for the generation in pigs of influenza A viruses with pandemic potential" 72 : 7367-7373, 1998
• 11 Nguyen DC, "Isolation and characterization of avian influenza viruses, including highly pathogenic H5N1, from poultry in live bird markets in Hanoi, Vietnam, in 2001" 79 : 4201-4212, 2005
• 12 FSIS, "Interagency risk assessment for the public health impact of highly pathogenic avian influenza virus in poultry, shell eggs, and egg products" 2010
• 13 McBride G, "Freshwater Microbiology research programme report: pathogen occurrence and human health risk assessment analysis" Ministry of Health 2002
• 14 de Jong MD, "Fatal avian influenza A (H5N1) in a child presenting with diarrhea followed by coma" 352 : 686-691, 2005
• 15 Snyder MH, "Evaluation of live avian-human reassortant influenza A H3N2 and H1N1 virus vaccines in seronegative adult volunteers" 23 : 852-857, 1986
• 16 Clements ML, "Evaluation of avian-human reassortant influenza A/Washington/897/80x A/Pintail/119/79 virus in monkeys and adult volunteers" 24 : 47-51, 1986
• 17 Haas CN, "Estimation of risk due to low-doses of microorganisms - a comparison of alternative methodologies" 118 : 573-582, 1983
• 18 Clements ML, "Dose response of A/Alaska/6/77 (H3N2) coldadapted reassortant vaccine virus in adult volunteers: role of local antibody in resistance to infection with vaccine virus" 40 : 1044-1051, 1983
• 19 Dybing JK, "Distinct pathogenesis of Hong Kong-origin H5N1 viruses in mice compared to that of other highly pathogenic H5 avian influenza viruses" 74 : 1443-1450, 2000
• 20 Clements ML, "Comparison of the virologic and immunologic responses of volunteers to live avian-human influenza A H3N2 reassortant virus vaccines derived from two different avian influenza virus donors" 27 : 219-222, 1989
• 21 Holcomb DL, "Comparison of six dose-response models for use with food-borne pathogens" 19 : 1091-1100, 1999
• 22 Shortridge KF, "Characterization of avian H5N1 influenza viruses from poultry in Hong Kong" 252 : 331-342, 1998
• 23 Capua I, "Avian influenza and human health" 83 : 1-6, 2002
• 24 Lu X, "A mouse model for the evaluation of pathogenesis and immunity to influenza A (H5N1) viruses isolated from humans" 73 : 5903-5911, 1999